REGISTERED
on 20 Feb 2024
Last Applicant/ Owned by
CH-4051 Basel
CH
Serial Number
79363621 filed on 04th Nov 2022
Registration Number
7307495 registered on 20th Feb 2024
Correspondent Address
Dwayne K. Goetzel
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
ROCKETVAX
Research and development in the fields of biology, pharmacy, immunology, oncology, DNA-based technologies, genetic engineering and vaccines; scientific research and development for medical purposes in the field of cancerous diseases; DNA verification in the nature of DNA screening for scientific research purposes; conducting and evaluation of scientific feasibility studies, in particular medical a Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services; pharmaceutical compounding consultant services; medical and pharmaceutical compounding services; preparation of medical and pharmaceutical reports with respect to treatment of individuals; performing RNA and DNA analyses for medical and veterinary purposes relating to the treatment of patients; conducting medical analysis relating to the treatment of patients; medical testing for diagnostic or treatment purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment; advice concerning all the aforesaid services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Research and development in the fields of biology, pharmacy, immunology, oncology, DNA-based technologies, genetic engineering and vaccines; scientific research and development for medical purposes in the field of cancerous diseases; DNA verification in the nature of DNA screening for scientific research purposes; conducting and evaluation of scientific feasibility studies, in particular medical and pharmaceutical studies; development of diagnostic methods and testing procedures; preparation of scientific reports; advice concerning all the aforesaid services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical products, substances and preparations in particular for the prevention and treatment of infectious and cancerous diseases; vaccines, in particular viral and DNA-based and RNA-based vaccines; preparations for vaccines; adjuvants and additives for vaccines; additives for vaccines; biochemical substances for medical or veterinary use, namely, for the prevention and treatment of infectious and cancerous diseases; synthetic DNA for medical or veterinary use, namely, for the prevention and treatment of infectious and cancerous diseases; pharmaceutical diagnostic agents for medical use; pharmaceutical preparations and compositions for cancer treatment and cancer prevention
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Industrial chemicals; chemical preparations for scientific purposes; active chemical ingredients used in the manufacture of anti-cancer drugs
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79363621
Mark Type
No Service Mark
Attorney Docket Number
No 5982-11100
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.01.29 -
Helixes
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Aug 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 18th Jul 2024 | FINAL DISPOSITION PROCESSED |
| 18th Jul 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 21st May 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 20th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 20th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
| 05th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 05th Dec 2023 | PUBLISHED FOR OPPOSITION |
| 04th Dec 2023 | NOTIFICATION PROCESSED BY IB |
| 15th Nov 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |